Organization
Univ of Toronto, Toronto, ON, Canada
1 abstract
Abstract
ACHIEVING ASDAS-CRP MAJOR IMPROVEMENT AND INACTIVE DISEASE IN PATIENTS WITH ANKYLOSING SPONDYLITIS AFTER TREATMENT WITH GOLIMUMAB IS ASSOCIATED WITH NORMALIZED HEALTH RELATED QUALITY OF LIFE: TWO-YEAR RESULTS FROM THE GO-RAISE TRIAL Org: Leiden Univ Medical Center, Leiden, Netherlands, Oregon Health and Science Univ, Portland, OR, United States, Rheumazentrum Ruhrgebiet, Herne, Germany, Janssen Research & Development, LLC, Spring House, PA, Janssen Global Service, LLC, Malvern, PA, United States,